Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market- Company Profile (Astellas Inc., Johnson & Johnson, Sanofi S.A, Dendreon Corporation, Bayer AG, and others have been provided in the report.)and Competitive intelligence report 2017

TOC

Chapter: 1 COMPANY PROFILES

1.1 Johnson & Johnson

1.1.1 Company Overview

1.1.2 Johnson & Johnson Snapshot

1.1.3 Operating Business Segment Overview

1.1.4 Financial performance

1.1.5 Strategic moves and developments

1.1.5.1 PRINCIPAL STRATEGIES: PRODUCT LAUNCH

1.1.5.2 SECONDARY STRATEGIES: APPROVALS

1.1.5.3 OTHER STRATEGIES: ACQUISITIONS

1.1.6 SWOT analysis and strategic deductions

1.2 Dendreon Corporation

1.2.1 Company Overview

1.2.2 Dendreon Corporation Snapshot

1.2.3 Operating Business Segment Overview

1.2.4 Financial performance

1.2.5 Strategic moves and developments

1.2.6 SWOT analysis and strategic deductions

1.3 Sanofi

1.3.1 Company Overview

1.3.2 Sanofi Snapshot

1.3.3 Operating Business Segment Overview

1.3.4 Financial performance

1.3.5 Strategic moves and developments

1.3.6 SWOT analysis and strategic deductions

1.4 Bayer

1.4.1 Company Overview

1.4.2 Bayer Snapshot

1.4.3 Operating Business Segment Overview

1.4.4 Financial performance

1.4.5 Strategic moves and developments

1.4.6 SWOT analysis and strategic deductions

1.5 Astellas Pharma Inc.

1.5.1 Company Overview

1.5.2 Astellas Snapshot

1.5.3 Operating Business Segment Overview

1.5.4 Financial performance

1.5.5 Strategic moves and developments

1.5.6 SWOT analysis and strategic deductions

LIST OF TABLES AND FIGURES

TABLE 1 COMPANY SNAPSHOT OF JOHNSON & JOHSNON

TABLE 2 JOHNSON & JOHSNON OPERATING SEGMENTS

TABLE 3 COMPANY SNAPSHOT OF DENDREON CORPORATION

TABLE 4 DENDREON CORPORATION OPERATING SEGMENTS

TABLE 5 COMPANY SNAPSHOT OF SANOFI

TABLE 6 SANOFI OPERATING SEGMENTS

TABLE 7 COMPANY SNAPSHOT OF BAYER

TABLE 8 BAYER OPERATING SEGMENTS

TABLE 9 COMPANY SNAPSHOT OF ASTELLAS

TABLE 10 ASTELLAS OPERATING SEGMENTS